BEACON introduced another promising multiple Tyrosine kinase inhibitor, Cabozanitib, under the brand name of Cabozanix for global market.
Cabozanitib is an anticancer drug for
Renal Cell Carcinoma
Metastatic Thyroid Cancer
Cabozanix is an oral Capsule preparation which is available in the strengths of 20 mg & 80mg. Each pack Cabozanix 20 contains 90 capsules and Cabozanix 80 contains30 capsules per HDPE pot. This product is only for export.
To know more visit our website: